Hemnet Faces a Sharp Slide Amid Analyst Skepticism

Hemnet (HEM.ST) has fallen 5.6 % in the 24‑hour trading window that closed at 05:55 PM Central Europe on Tuesday, 20 October 2026. A single share now trades at roughly SEK 73.45 on the major exchanges, a price that sits well below its 200‑day simple moving average of SEK 101.88. With a market capitalization of SEK 6.2 bn, the company’s shares have traded a mere SEK 28.9 mn in the last 24 hours, signalling a liquidity squeeze that investors may find unsettling.

Market Context and Recent Performance

The drop is not an isolated incident. Hemnet has declined 3.92 % since the end of last month, a trend that mirrors the broader erosion of confidence in Sweden’s online property sector. The company’s peak over the past year was a staggering SEK 240.6 on 24 October 2025, while the 52‑week low of SEK 63.15 on 25 September 2026 has already been breached. The current price of SEK 73.45 sits above the low but still far from the historical high, underscoring a sustained slide in valuation.

Analysts React to a “Street Low”

The recent sharp decline follows a “street low” rating from Kepler Cheuvreux and a subsequent reduction in target price by ABG Sundal Collier. These moves have forced the market to re‑evaluate Hemnet’s growth prospects. While the shares have not yet plunged to the levels suggested by the analysts, the 70 SEK floor that the market settled near after the dip indicates that investors are still wary of the company’s trajectory. The consensus among analysts remains cautious, with many maintaining a holding stance and pointing to weaker‑than‑expected listing volumes in the latest quarter.

Upcoming Earnings: A Litmus Test

Hemnet’s third‑quarter earnings report, due Thursday, will be a critical test of the company’s resilience. If the company fails to deliver a rebound in adjusted earnings, the stock could face further downward pressure, potentially eroding investor confidence to new lows. Conversely, a surprise improvement could reinvigorate the market, but given the current sentiment, any gains would likely be modest at best.

Peer Comparison: A Broader Industry Headwind

The slump is echoed across several peers:

  • Investment Oresund (ORES.ST): down 0.82 %, trading at SEK 146.6, with a low price‑to‑earnings ratio of 5.34, signalling undervaluation yet persistent weakness.
  • Raysearch Laboratories (RAY‑B.ST): down 1.07 %, trading at SEK 194.4, faces a high P/E of 31.35 but anticipates modest earnings growth in the coming quarter.
  • Xvivo Perfusion (XVIVO.ST): modest rise of 0.17 % to SEK 229.6, with a P/E of 82.37, suggesting overvaluation but buoyed by strong Q3 expectations.
  • Corem Property (CORED.ST): flat at SEK 193.4, with a market cap of SEK 7.1 bn, expecting a small earnings‑per‑share improvement but a slight revenue decline.
  • Platzer Fastigheter Hold (PLAZ‑B.ST): down 1.63 % to SEK 61.8, with a P/E of 9.4, indicating potential undervaluation yet facing downward pressure.

These peers collectively illustrate that Hemnet is not alone in grappling with sluggish growth and cautious investor sentiment. The sector’s valuation compression is tightening, and only a clear turnaround in revenue and listing volume can reverse the current narrative.

Strategic Implications

Hemnet’s core business—an online property platform for Swedish real estate—remains constrained by a domestic market that is increasingly saturated and price‑sensitive. The company’s reliance on a single country exposes it to regional economic shocks and regulatory changes that can stifle growth. Unless Hemnet diversifies its service offerings or expands into new markets, its valuation will likely remain tethered to a shrinking domestic demand curve.

Conclusion

Hemnet’s recent 5.6 % slide is a stark reminder that the Swedish property‑listing market is under pressure. Analyst downgrades, weak listing volumes, and a market that is still skeptical of the company’s future earnings all contribute to a fragile outlook. The upcoming earnings announcement will be pivotal—failure to meet expectations could trigger a deeper sell‑off, while any modest improvement may only marginally buoy the stock. Investors should approach Hemnet with caution, recognizing that the company’s current trajectory is far from the optimistic projections that once characterized its market presence.